Why the study?
Can an ELISA method using monoclonal antibodies accurately quantify platelet GPIb to diagnose homozygous and heterozygous states of Bernard-Soulier syndrome?
Can an ELISA method using monoclonal antibodies accurately quantify platelet GPIb to diagnose homozygous and heterozygous states of Bernard-Soulier syndrome?
An ELISA method using monoclonal antibodies provides a simple and precise way to quantify platelet GPIb for diagnosing homozygous and heterozygous Bernard-Soulier syndrome.
This is the authors' abstract. We don't add key points for this paper.
Two unrelated patients with Bernard-Soulier syndrome and their relatives were studied. The patients demonstrated severe bleeding diathesis, the relatives were asymptomatic. The propositi showed the characteristic abnormalities of the syndrome: thrombocytopenia, a percentage of giant platelets higher than 65%, prolonged bleeding time and defective platelet aggregation to ristocetin and bovine plasma. On the contrary, in the heterozygotes, the typical abnormalities were not fully evident. We introduce a simple ELISA method for the precise definition of both homozygous and heterozygous states for the syndrome by the quantitation of platelet glycoprotein (GP) Ib. Specific binding of monoclonal antibodies anti-platelet GPIb was performed both by direct binding of radioiodinated antibody and by ELISA. Comparable results were obtained. In fact, we demonstrated near absence of GPIb in the 2 propositi and about half the amount in the heterozygotes studied compared to normal platelets.
Answers are grounded in this paper and cite their sources.
May support ELISA for GPIb quantification in Bernard-Soulier cases; leaves open validation before routine diagnostic use.
No takes yet. Share an insight, caveat, or question.
Marco et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: